CARGO Therapeutics Management
Management criteria checks 0/4
CARGO Therapeutics' CEO is Gina Chapman, appointed in May 2022, has a tenure of 2.5 years. total yearly compensation is $4.99M, comprised of 10.9% salary and 89.1% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $1.69M. The average tenure of the management team and the board of directors is 1.3 years and 1.5 years respectively.
Key information
Gina Chapman
Chief executive officer
US$5.0m
Total compensation
| CEO salary percentage | 10.9% |
| CEO tenure | 2.5yrs |
| CEO ownership | 0.2% |
| Management average tenure | 1.3yrs |
| Board average tenure | 1.5yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$154m |
| Jun 30 2024 | n/a | n/a | -US$148m |
| Mar 31 2024 | n/a | n/a | -US$121m |
| Dec 31 2023 | US$5m | US$542k | -US$98m |
| Sep 30 2023 | n/a | n/a | -US$80m |
| Jun 30 2023 | n/a | n/a | -US$57m |
| Mar 31 2023 | n/a | n/a | -US$46m |
| Dec 31 2022 | US$825k | US$333k | -US$41m |
Compensation vs Market: Gina's total compensation ($USD4.99M) is above average for companies of similar size in the US market ($USD3.17M).
Compensation vs Earnings: Gina's compensation has increased whilst the company is unprofitable.
CEO
Gina Chapman (57 yo)
2.5yrs
Tenure
US$4,992,389
Compensation
Ms. Gina Chapman serves as Independent Director of Entrada Therapeutics, Inc. since September 01, 2023. She is President, Chief Executive Officer and Director of Cargo Therapeutics, Inc from May 02, 2022....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$4.99m | 0.23% $ 1.7m | |
| Co-Founder & Scientific Advisory Board Chair | no data | US$160.00k | 0.061% $ 452.6k | |
| CFO, Secretary & COO | 2.3yrs | US$2.51m | 0.014% $ 104.6k | |
| Chief Medical Officer | 1.1yrs | US$2.63m | 0% $ 0 | |
| Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Senior Vice President of Finance & Accounting | 1.3yrs | no data | no data | |
| Chief Technical Officer | 2.8yrs | US$693.19k | 0.064% $ 478.5k | |
| Chief Scientific Officer | 1.3yrs | no data | no data | |
| Chief Legal Officer | 1.3yrs | no data | no data | |
| Head of Marketing | 1.1yrs | no data | no data |
1.3yrs
Average Tenure
56yo
Average Age
Experienced Management: CRGX's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$4.99m | 0.23% $ 1.7m | |
| Co-Founder & Scientific Advisory Board Chair | less than a year | US$160.00k | 0.061% $ 452.6k | |
| Co-Founder & Scientific Advisory Board Member | less than a year | no data | no data | |
| Independent Chairman of the Board | 2.2yrs | US$818.60k | 0% $ 0 | |
| Independent Director | 1.3yrs | US$514.13k | 0% $ 0 | |
| Independent Director | 1.7yrs | US$303.97k | 0% $ 0 | |
| Board Observer | no data | no data | no data | |
| Member Scientific Advisory Board | less than a year | no data | no data | |
| Director | 3.8yrs | US$306.39k | 0% $ 0 | |
| Independent Director | 2.1yrs | US$441.51k | 0% $ 0 | |
| Board Observer | no data | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
1.5yrs
Average Tenure
52yo
Average Age
Experienced Board: CRGX's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.